Fundai

Tolid Darou Pharmaceutical Company (DTOLID) cash flow statement

Operating, investing and financing cash flows, and the closing balance

Ticker
DTOLID
Industry
Pharmaceuticals
Market
Iran Fara Bourse

Latest periods

Latest 9-month periods, in million rials
ItemTo 1405/06/31To 1404/06/31To 1403/09/30To 1402/09/30To 1401/09/30To 1400/09/30
Cash generated from operations302,642-780,793-90,898837,680146,112-265,409
Cash payments for income tax-30,415-36,192-153,796-83,858-19,643-3,221
Net cash inflow (outflow) from operating activities272,227-816,985-244,694753,822126,469-268,630
Cash payments for purchase of property, plant and equipment-21,010-104,610-24,705-85,873-101,859-8,321
Cash payments for purchase of intangible assets-1,945-16,4330-37100
Cash receipts from interest on other investments1741291,23610,7436,0129,294
Net cash inflow (outflow) from investing activities-22,781-89,20222,867-75,530-95,847973
Net cash inflow (outflow) before financing activities249,446-906,187-221,827678,29230,622-267,657
Cash receipts from sale of treasury shares79,38887,71995,570403,86852,0010
Cash payments for purchase of treasury shares-129,562-118,596-146,095-394,665-70,4010
Cash receipts from facilities4,325,0461,875,4442,964,9482,272,9711,059,6052,639,682
Cash payments for principal of loans-4,042,972-1,139,660-1,864,173-2,422,920-882,888-2,192,065
Cash payments for interest on loans-429,037-644,003-719,116-506,237-63,985-275,873
Cash payments for dividends-1810-205,693-27,989-81,898-33,119
Net cash inflow (outflow) from financing activities-197,318605,078423,516-667,91712,434251,080
Net increase (decrease) in cash52,128-301,109201,68910,37543,056-16,577
Cash balance at beginning of year309,105381,961178,597313,75174,58968,098
Cash balance at end of year361,23380,852381,961324,126117,64551,521
Non-cash transactions3,614,6000957,751000

Reporting periods

56 periods are on file for this report, from the period ending 1390/12/29 to the period ending 1405/06/31.